Table 2 Study demographics and outcomes for the HP and PRA group
From: Primary resection anastomosis versus Hartmann’s procedure in Hinchey III and IV diverticulitis
Observational studies | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belmonte | 1996 | 27 | NR | NR | 1 | 3.7% | Open | 85 | 3 | NR | NR | 16 | 2 | 2.4% | Open |
Berry | 1989 | 6 | NR | NR | 3 | 50.0% | Open | 1 | NR | NR | NR | NR | 0 | 0.0% | Open |
Binda | 1993 | 17 | NR | 1 | 6 | 35.3% | Open | 9 | NR | 1 | NR | NR | 1 | 11.1% | Open 30, lap 4 |
Drumm | 1984 | 5 | NR | NR | 1 | 20.0% | Open | 3 | NR | NR | NR | NR | 2 | 66.7% | NR |
Gawlick | 2012 | 1678 | NR | 226 | 104 | 6.2% | NR | 340 | NR | 40 | NR | 210 | 19 | 5.6% | Open |
Gooszen | 2001 | 19 | NR | NR | 4 | 21.1% | Open | 21 | NR | NR | NR | 32 | 3 | 14.3% | Open |
Hold | 1990 | 31 | NR | NR | 6 | 19.4% | Open | 16 | NR | NR | NR | 5 | 3 | 18.8% | Open |
Makela | 2002 | 47 | NR | NR | 6 | 12.8% | Open | 1 | NR | NR | NR | NR | 0 | 0.0% | Open |
Medina | 1991 | 3 | NR | NR | 1 | 33.3% | Open | 3 | 0 | 0 | NR | NR | 0 | 0.0% | Open |
Nagorney | 1985 | 84 | NR | NR | 6 | 7.1% | Open | 4 | NR | NR | NR | 4 | 0 | 0.0% | Open |
Peoples | 1990 | 25 | NR | NR | 6 | 24.0% | Open | 11 | 0 | NR | NR | NR | 2 | 18.2% | Open |
Regenet | 2003 | 33 | 5 | 9 | 4 | 12.1% | Open | 27 | 3 | 2 | 3 | 27 | 3 | 11.1% | Open |
Richter | 2006 | 5 | NR | NR | 3 | 60.0% | Open | 36 | 1 | NR | NR | 3 | 4 | 11.1% | Open |
Saccomani | 1993 | 7 | NR | NR | 3 | 42.9% | Open | 11 | 0 | NR | NR | 5 | 1 | 9.1% | Open |
Schilling | 2001 | 42 | 3 | NR | 3 | 7.1% | Open | 13 | NR | NR | NR | NR | 1 | 7.7% | Open |
Thaler | 2000 | 62 | NR | NR | 22 | 35.5% | Open | 20 | NR | NR | NR | NR | 4 | 20.0% | Open |
Trenti | 2011 | 60 | NR | 19 | 27 | 45.0% | Open | 27 | 3 | 10 | NR | 5 | 2 | 7.4% | Open |
Tucci | 1996 | 7 | NR | NR | 1 | 14.3% | Open | 1 | NR | NR | 0 | NR | 0 | 0.0% | Open |
Tudor | 1994 | 40 | NR | NR | 10 | 25.0% | Open | 8 | 0 | NR | NR | NR | 6 | 75.0% | Open |
Vennix | 2016 | 240 | NR | NR | 18 | 7.5% | Open | 67 | NR | NR | NR | NR | 0 | 0.0% | Open |
Vermeulen | 2007 | 95 | NR | NR | 36 | 37.9% | Open | 26 | NR | NR | NR | NR | 7 | 26.9% | Open |
Wedell | 1997 | 15 | NR | NR | 4 | 26.7% | Open | 14 | 0 | NR | NR | 4 | 1 | 7.1% | Open |
2548 | 8 | 255 | 275 | 10.8% | 744 | 7 | 53 | 3 | 295 | 61 | 8.2% | ||||
Randomized control trials (RCTs) | |||||||||||||||
Binda | 2012 | 56 | NR | 20 | 6 | 11% | Open 53,lap 3 | 34 | 1 | 15 | NR | 34 | 1 | 2.9% | Open |
Bridoux | 2017 | 52 | NR | NR | 3 | 6% | Open | 50 | 2 | NR | NR | 50 | 1 | 2.0% | Open |
Oberkofler | 2012 | 30 | NR | NR | 4 | 13% | Open | 32 | NR | NR | NR | 32 | 3 | 9.4% | Open |
138 | 0 | 20 | 13 | 9.4% | 116 | 3 | 15 | 0 | 116 | 5 | 4.3% | ||||